Subarood Tablets 20mg (Rosuvastatin Calcium (Unmicronized))

Adult dose

This medication is an orodispersible tablet that should be placed on the tongue and dissolved without water. The initial dose is 5 mg once daily, while the maintenance dose is typically 10 mg once daily, which is sufficient for most patients. The maintenance dose may be adjusted based on LDL cholesterol levels, treatment goals, and patient response, with an increase up to a maximum of 20 mg once daily if necessary, usually after a four-week or longer interval.

Child dose

This medication is an orodispersible tablet that should be placed on the tongue and dissolved without water. The usual dosage range for pediatric patients (aged 10 to 17 years) is 5 mg to 20 mg, administered once daily. The dosage should be adjusted based on individual response.

This medication should not be administered to certain patients. For example, those who are allergic to any component of this medication or have severe liver dysfunction, as well as patients with muscle disorders, should not use it. Additionally, patients with very poor kidney function, women who are pregnant or nursing, and women of childbearing age who are not using adequate contraception should not take this medication. High-dose use is especially prohibited in patients at risk for muscle disorders. As this medication may affect liver function, caution should be exercised in patients who excessively consume alcohol or have a history of liver disease. It is advisable to repeat liver function tests before and during treatment. If symptoms such as myalgia or muscle weakness occur, the physician should be notified immediately, and discontinuation of the medication may be necessary. This medication should be used cautiously in patients at risk for muscle damage, and it is recommended to check muscle enzyme levels prior to treatment. In the event of acute illness or severe conditions, discontinuation of this medication may be necessary. This medication can interact with other drugs, so it is essential to inform the physician of any other medications being taken. In particular, co-administration with certain antivirals, immunosuppressants, and antifungal agents may increase the risk of muscle damage. Women who are pregnant or may become pregnant should not take this medication, and adequate contraception is essential. Nursing mothers should also avoid taking this medication. In the case of overdose, there is no specific antidote, and treatment should be symptomatic while monitoring liver function and muscle enzyme levels. This medication does not significantly affect the ability to drive or operate machinery, but caution should be exercised as dizziness may occur.

Serious side effects

Allergic reactions including urticaria and angioedema, rhabdomyolysis, immune-mediated necrotizing myopathy, severe muscle weakness, ophthalmoplegia, shortness of breath, cough, hepatitis, jaundice, Stevens-Johnson syndrome, edema, thrombocytopenia, acute kidney failure, oliguria, fatal and non-fatal hepatic failure, interstitial lung disease

Mild side effects

• Headache
• dizziness
• constipation
• nausea
• abdominal pain
• itching
• rash
• myalgia
• weakness
• diarrhea

This medication may be sensitive to air or moisture, so it should be stored in a tightly closed container. It is advisable to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature to ensure the medication's efficacy and safety over time.

Appearance

White to light yellow round orodispersible tablet

Package unit

30 tablets/box [10 tablets/PTP × 3], 10 tablets/box [10 tablets/PTP × 1]